Buy Toviaz 4 mg/1 fesoterodine fumarate

Toviaz 4 mg is an extended-release tablet containing fesoterodine fumarate, used for managing overactive bladder symptoms. This medication helps control bladder function and reduce urinary urgency.

Strength

4 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0242-30)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Toviaz 4 mg is primarily used for the treatment of overactive bladder (OAB) symptoms, such as urinary urgency, frequency, and incontinence. It works by relaxing the bladder muscles, which can help improve bladder control and reduce the sudden need to urinate. People often ask, 'What is Toviaz used for?' and the answer is that it is designed to manage these specific bladder-related issues.

Side Effects

Common effects of Toviaz 4 mg may include dry mouth, constipation, and blurred vision. Some users might experience dizziness or headaches. These effects can vary from person to person and are generally mild to moderate in nature.

Precautions & Warnings

Toviaz 4 mg should be handled with care, especially by individuals with certain medical conditions such as glaucoma or urinary retention. It is important to follow the guidance of a healthcare provider when starting or adjusting the use of this medication. Always store the tablets in a cool, dry place away from direct sunlight.

Avoid Interactions

Toviaz 4 mg may interact with other medications, particularly those that affect the central nervous system or cause drowsiness. Alcohol consumption should be avoided as it can enhance the sedative effects. It is also important to be cautious when taking other medications that affect bladder function or digestion.

References

Frequently Asked Questions

Toviaz 4 mg is used to manage symptoms of overactive bladder, including urinary urgency, frequency, and incontinence.

Toviaz 4 mg works by relaxing the bladder muscles, which helps to improve bladder control and reduce the sudden need to urinate.

Common side effects may include dry mouth, constipation, blurred vision, dizziness, and headaches.

It is important to consult a healthcare provider before taking Toviaz 4 mg with other medications, as interactions can occur.

Toviaz 4 mg should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.